ACADIA Pharmaceuticals Inc logo

ACADIA Pharmaceuticals Inc

2
1
NAS:ACAD (USA)   Ordinary Shares
$ 18.72 +0.24 (+1.3%) 11:09 PM EST
At Loss
P/B:
7.15
Volume:
1.94M
Avg Vol (2M):
1.91M
Also Trade In:
Volume:
1.94M
At Loss
Avg Vol (2M):
1.91M

Business Description

ACADIA Pharmaceuticals Inc logo
ACADIA Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US0042251084

Share Class Description:

ACAD: Ordinary Shares
Description
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Name Current Vs Industry Vs History
Cash-To-Debt 7.67
Equity-to-Asset 0.58
Debt-to-Equity 0.13
Debt-to-EBITDA -0.84
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.54
Distress
Grey
Safe
Beneish M-Score -1.7
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 18.39
9-Day RSI 21.81
14-Day RSI 25.55
6-1 Month Momentum % 2.83
12-1 Month Momentum % 26.82

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.42
Quick Ratio 2.28
Cash Ratio 1.73
Days Inventory 137.65
Days Sales Outstanding 40.3
Days Payable 138.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1
Shareholder Yield % -0.67

Financials (Next Earnings Date:2024-05-08 Est.)

ACAD's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ACAD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ACADIA Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 726.437
EPS (TTM) ($) -0.38
Beta 0.47
Volatility % 61.68
14-Day RSI 25.55
14-Day ATR ($) 1.220006
20-Day SMA ($) 22.99625
12-1 Month Momentum % 26.82
52-Week Range ($) 17.71 - 33.99
Shares Outstanding (Mil) 164.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ACADIA Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

ACADIA Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ACADIA Pharmaceuticals Inc Frequently Asked Questions

What is ACADIA Pharmaceuticals Inc(ACAD)'s stock price today?
The current price of ACAD is $18.72. The 52 week high of ACAD is $33.99 and 52 week low is $17.71.
When is next earnings date of ACADIA Pharmaceuticals Inc(ACAD)?
The next earnings date of ACADIA Pharmaceuticals Inc(ACAD) is 2024-05-08 Est..
Does ACADIA Pharmaceuticals Inc(ACAD) pay dividends? If so, how much?
ACADIA Pharmaceuticals Inc(ACAD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1